Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of ARA and TUDCA Supplements on Influenza Vaccine Response in Elderly
NCT06827873Not yet recruiting
- Sponsor
- Tsinghua University
- Start
- Feb 2025
- Primary completion
- May 2025
- Countries
- 1
01
Overview
Randomised, double-blind trial (3 arms), sponsored by Tsinghua University. Primary endpoints: Specific Antibody Levels to Influenza Vaccine at Day 24 and Neutralizing Antibody Responses to Influenza Vaccine at Day 24. Planned start Feb 2025; status: not yet recruiting.
Beyond the preview
Go deeper on NCT06827873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06827873.